Loading
Medical oncologist who heads Japan's Pharmaceuticals and Medical Devices Agency, the national drug and device regulator.
Yasuhiro Fujiwara, MD, PhD, is Chief Executive of the Pharmaceuticals and Medical Devices Agency (PMDA), Japan's regulatory authority for drugs and medical devices. A medical oncologist formerly at the National Cancer Center Japan, he brings a cancer drug development background to regulatory review and international regulatory harmonisation.
| Title | Journal | Year |
|---|---|---|
| Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs | Clinical and Translational Science | 2021 |
| Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers | Frontiers in Oncology | 2021 |
| Regulatory Issues: PMDA – Review of Sakigake Designation Products: Oncolytic Virus Therapy with Delytact Injection (Teserpaturev) for Malignant Glioma | The Oncologist | 2023 |
Shares The oncologist and the tags leadership, drug development.
Shares The oncologist and the tag leadership.
Shares The oncologist and the tag leadership.
Shares the tags leadership, regulation.
Shares the tags leadership, regulation.
Shares the tags leadership, regulation.
Shares the tags leadership, regulation.
Shares the tags leadership, regulation.